Severe Plasmodium vivax malaria in Pakistan

Emerging Infectious Diseases

Volumn 19, Issue 11, 2013, Pages 1851-1854

  Zubairi, Ali Bin Sarwar ^a   Nizami, Sobia ^a   Raza, Afsheen ^a   Mehraj, Vikram ^b   Rasheed, Anita Fazal ^a   Ghanchi, Najia Karim ^a   Khaled, Zahra Nur ^a   Beg, M Asim ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANEMIA; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD SMEAR; COMORBIDITY; CONSCIOUSNESS DISORDER; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEMOGLOBINURIA; HUMAN; HYPERPYREXIA; HYPOGLYCEMIA; INCIDENCE; INFECTION RISK; JAUNDICE; LIVER DYSFUNCTION; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; METABOLIC ACIDOSIS; MIXED INFECTION; MORTALITY; MULTIPLE ORGAN FAILURE; PAKISTAN; PARASITE TRANSMISSION; PLASMODIUM VIVAX MALARIA; PREVALENCE; RETROSPECTIVE STUDY; SECONDARY INFECTION; SERODIAGNOSIS; SHOCK; THROMBOCYTOPENIA;

MALARIA, SEVERE MALARIA, COMPLICATIONS, PLASMODIUM VIVAX, PAKISTAN; PARASITES;

ADULT; CROSS-SECTIONAL STUDIES; HOSPITALIZATION; HUMANS; MALARIA, FALCIPARUM; MALARIA, VIVAX; MIDDLE AGED; PAKISTAN; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PUBLIC HEALTH SURVEILLANCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84886998106     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1911.130495     Document Type: Article

References (11)

1. World Health Organization. World malaria report: 2011. Geneva: The Organization; 2011.
2. Imwong M, Pukrittayakamee S, Grüner AC, Rénia L, Letourneur F, Looareesuwan S, et al. Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1. Malar J. 2005; 4: 20. http://dx. doi. org/10. 1186/1475-2875-4-20.
3. Zakeri S, Bereczky S, Naimi P, Pedro Gil J, Djadid ND, Färnert A, et al. Multiple genotypes of the merozoite surface proteins 1 and 2 in Plasmodium falciparum infections in a hypoendemic area in Iran. Trop Med Int Health. 2005; 10: 1060-4. http://dx. doi. org/10. 1111/j. 1365-3156. 2005. 01477. x.
4. World Health Organization. Guidelines for the treatment of malaria, 2nd ed. Geneva: The Organization; 2010.
5. Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol. 2004; 57: 1288-94. http://dx. doi. org/10. 1016/j. jclinepi. 2004. 03. 012.
6. Beg MA, Sani N, Mehraj V, Jafri W, Khan MA, Malik A, et al. Comparative features and outcomes of malaria at a tertiary care hospital in Karachi, Pakistan. Int J Infect Dis. 2008; 12: 37-42. http://dx. doi. org/10. 1016/j. ijid. 2007. 04. 006.
7. Price RN, Douglas NM, Anstey NM. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Curr Opin Infect Dis. 2009; 22: 430-5. http://dx. doi. org/10. 1097/QCO. 0b013e32832f14c1.
8. Douglas NM, Anstey NM, Buffet PA, Poespoprodjo JR, Yeo TW, White NJ, et al. The anaemia of Plasmodium vivax malaria. Malar J. 2012; 11: 135. http://dx. doi. org/10. 1186/1475-2875-11-135.
9. Sharma A, Khanduri U. How benign is benign tertian malaria? J Vector Borne Dis. 2009; 46: 141-4.
10. Kochar DK, Das A, Kochar SK, Saxena V, Sirohi P, Garg S, et al. Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. Am J Trop Med Hyg. 2009; 80: 194-8.
11. Mueller I, Galinski MR, Baird JK, Carlton JM, Kochar DK, Alonso PL, et al. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis. 2009; 9: 555-66. http://dx. doi. org/10. 1016/S1473-3099(09)70177-X.